Device Diagnostics Information Solutions

Navify Poc Operations

Payments companies reported to CMS as associated with Navify Poc Operations. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,464associated payments (2023-2025)
26clinicians with associated payments
1company reporting

By year

2025 $1,464

Payments reported as associated with Navify Poc Operations, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $824
Clinical Pathology/Laboratory Medicine $322
Dermatopathology (Pathology) $115
Anatomic Pathology $85.44
Family $58.56
Pediatrics $39.04

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Navify Poc Operations

These are the largest totals companies reported as associated with Navify Poc Operations. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Keri Donaldson Danville, PA Clinical Pathology/Laboratory Medicine $322.10
Myra Wilkerson Danville, PA Anatomic Pathology & Clinical Pathology $208.52
Angelo Demarzo Baltimore, MD Anatomic Pathology & Clinical Pathology $148.83
Jeffrey Prichard Danville, PA Anatomic Pathology & Clinical Pathology $121.68
Drazen Jukic Savannah, GA Dermatopathology (Pathology) $114.61
Anthony Magliocco Orlando, FL Anatomic Pathology $68.42
Stephen Hammond Myrtle Beach, SC Anatomic Pathology & Clinical Pathology $62.32
David Ward Orlando, FL Anatomic Pathology & Clinical Pathology $34.76
Irina Perjar Chattanooga, TN Anatomic Pathology & Clinical Pathology $24.91
Sandra Barnick Hollywood, FL Anatomic Pathology & Clinical Pathology $24.91

Prescribed Navify Poc Operations?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.